Falco Walter JJ, Scheffer IE, Fisher RS. The new definition and classification of seizures and Epilepsy. Epilepsy Res. 2018;139:73–9.

Article  PubMed  Google Scholar 

Nadeem MS, Ahmad H, Mohammed K, Muhammad K, Ullah I, Baothman OAS, et al. Identification of variants in the mitochondrial lysine-tRNA (MT-TK) gene in myoclonic Epilepsy—pathogenicity evaluation and structural characterization by in silico approach. J Cell Biochem. 2018;119:6258–65.

Article  CAS  PubMed  Google Scholar 

Wahab A. Difficulties in treatment and management of Epilepsy and challenges in new drug development. Pharmaceuticals (Basel). 2010;3(7):2090–110.

Article  CAS  PubMed  Google Scholar 

Winawer MR, Marini C, Grinton BE, Rabinowitz D, Berkovic SF, Scheffer IE, et al. Familial clustering of seizure types within the idiopathic generalized epilepsies. Neurology. 2005;65(4):523–8.

Article  CAS  PubMed  Google Scholar 

Prasad DKV, Shaheen U, Satyanarayana U, Prabha TS, Jyothy A, Munshi A. Association of GABRA6 1519 T>C (rs3219151) and synapsin II (rs37733634) gene polymorphisms with the development of idiopathic generalized Epilepsy. Epilepsy Res. 2014;108:1267–73.

Article  CAS  PubMed  Google Scholar 

Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on classification and terminology, 2005–2009. Epilepsia. 2010;51(4):676–85.

Article  PubMed  Google Scholar 

Ottman R, Annegers JF, Risch N, Hauser WA, Susser M. Relations of genetic and environmental factors in the etiology of Epilepsy. Ann Neurol. 1996;39(4):442–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lakhan R, Kumari R, Misra UK, Kalita J, Pradhan S, Mittal B. Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with Epilepsy and multiple drug resistance in the north Indian population. Br J Clin Pharmacol. 2009;68(2):214–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaplan DI, Isom LL, Petrou S. Role of sodium channels in Epilepsy. Cold Spring HarbPerspect Med. 2016;6(6): a022814.

Article  Google Scholar 

Abe T, Seo T, Ishitsu T, Nakagawa T, Hori M, Nakagawa K. Association between SCN1A polymorphism and carbamazepine-resistant Epilepsy. Br J Clin Pharmacol. 2008;66(2):304–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daci A, Beretta G, Vllasaliu D, Shala A, Govori V, Norata GD, et al. Polymorphic variants of SCN1A and EPHX1 influence plasma carbamazepine concentration, metabolism and pharmacoresistance in a population of Kosovar Albanian epileptic patients. PLoS ONE. 2015;10(11): e0142408.

Article  PubMed  PubMed Central  Google Scholar 

Angelopoulou C, Veletza S, Heliopoulos I, Vadikolias K, Tripsianis G, Stathi C, et al. Association of SCN1A gene polymorphism with antiepileptic drug responsiveness in the population of Thrace, Greece. Arch Med Sci. 2017;13(1):138–47.

Article  CAS  PubMed  Google Scholar 

Fotoh AE, Abd El Naby WM, Habib SA, ALrefai MS, Kasemy AA. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children. Seizure. 2016;41:75–80.

Article  Google Scholar 

Olowe R, Sandouka S, Saadi A, Shekh-Ahmad T. Approaches for reactive oxygen species and oxidative stress quantification in Epilepsy. Antioxide. 2020;9(10): 990.

Article  CAS  Google Scholar 

Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh MF. Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s disease (AD): from risk factors to therapeutic targeting. Cells. 2020;9(2): 383.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:e17023.

Article  Google Scholar 

Rojas A, Jiang J, Ganesh T, Yang MS, Lelutiu N, Gueorguieva P, et al. Cyclooxygenase-2 in Epilepsy. Epilepsia. 2014;55(1):17–25.

Article  CAS  PubMed  Google Scholar 

Youn Y, Sung IK, Lee IG. The role of cytokines in seizures: interleukin (IL)-1b, IL-1Ra, IL-8, and IL-10. Korean J Pediatr. 2013;56(7):271–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi LM, Chen RJ, Zhang H, Jiang CM, Gong J. Cerebrospinal fluid neuron specific enolase, interleukin-1beta and erythropoietin concentrations in children after seizures. Childs Nerv Syst. 2017;33(5):805–11.

Article  PubMed  Google Scholar 

DeSena AD, Do T, Schulert GS. Systemic autoinflammation with intractable Epilepsy managed with interleukin-1 blockade. J Neuroinflamm. 2018;15(1):38.

Article  Google Scholar 

Mao LY, Ding J, Peng WF, Ma Y, Zhang YH, Fan W, et al. Interleukin-17A levels are elevated and correlate with seizure severity of Epilepsy patients. Epilepsia. 2013;54(9):e142–5.

Article  CAS  PubMed  Google Scholar 

Ishikawa N, Kobayashi Y, Fujii Y, Kobayashi M. Increased interleukin-6 and high-sensitivity C-reactive protein levels in pediatric Epilepsy patients with frequent, refractory generalized motor seizures. Seizure. 2015;25:136–40.

Article  PubMed  Google Scholar 

Yu N, Di Q, Hu Y, Zhang YF, Su LY, Liu XH, et al. A meta-analysis of pro-inflammatory cytokines in the plasma of epileptic patients with recent seizure. Neurosci Lett. 2012;514(1):110–5.

Article  CAS  PubMed  Google Scholar 

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant Epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on therapeutic strategies. Epilepsia. 2010;51(6):1069–77.

Article  CAS  PubMed  Google Scholar 

Fattorusso A, Matricardi S, Mencaroni E, Dell’Isola GB, Di Cara G, Striano P, et al. The pharmacoresistant Epilepsy: an overview on existant and new emerging therapies. Front Neurol. 2021;12:674483.

Article  PubMed  PubMed Central  Google Scholar 

Smolarz B, Makowska M, Romanowicz H. Pharmacogenetics of drug-resistant Epilepsy (review of literature). Int J Mol Sci. 2021;22(21): 11696.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fabisiak T, Patel M. Crosstalk between neuroinflammation and oxidative stress in Epilepsy. Front Cell Dev Biol. 2022;10: 976953.

Article  PubMed  PubMed Central  Google Scholar 

Walker LE, Sills GJ, Jorgensen A, Alapirtti T, Peltola J, Brodie MJ, et al. High-mobility group box 1 as a predictive biomarker for drug-resistant Epilepsy: a proof-of-concept study. Epilepsia. 2022;63(1):e1–6.

Article  CAS  PubMed  Google Scholar 

Ashfaq A, Saleem T, Sheikh N, Maqbool H. Genetic analysis of sodium channel genes in pediatric Epilepsy patients of Pakistan. Genet Res. 2022;2022:1168703.

Article  Google Scholar